We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Ariad names Hugh Cole CBO

News

Executive Summary

Ariad Pharmaceuticals has appointed of Hugh M Cole senior vice-president and chief business officer. Mr Cole has over 25 years' industry experience with a background in rare and orphan markets. Prior to joining Ariad, he spent seven years at Shire, most recently as senior vice-president of strategic planning and program management, and global franchise head.